FibroGen Inc (NAS:FGEN)
$ 1.19 0 (0%) Market Cap: 118.38 Mil Enterprise Value: 89.74 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Q3 2023 FibroGen Inc Earnings Call Transcript

Nov 06, 2023 / 10:00PM GMT
Release Date Price: $0.5592 (-13.62%)
Operator

Hello and welcome to FibroGen's Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. (Operator Instructions). Please be advised that today's conference is being recorded. It is now my pleasure to introduce Vice President of Investor Relations, David DeLucia.

David DeLucia

Good afternoon, everyone. Thank you for joining today to discuss our third quarter 2023 financial and business results. I'm David DeLucia, Vice President of Corporate FP&A and Investor Relations of FibroGen. Joining me on today's call are Thane Wettig, our Chief Executive Officer; Juan Graham, our Chief Financial Officer; Dr. John Hunter, our Chief Scientific Officer; and Christine Chung, our Senior Vice President of China Operations.

Following our prepared remarks, we will open the call to your questions. I would like to remind you that remarks made on today's call include forward-looking statements about FibroGen. Such statements may include, but are not limited to, our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot